Home » Newsletters » BioWorld

BioWorld

Oct. 18, 1995

View Archived Issues

CYTEL TAKES CONTROL OF VACCINE JOINT VENTURE FROM SCRIPPS

SHAMAN CHANGES TARGET FOR LEAD DRUG; PLANS PHASE II TRIALS

OTHER NEWS TO NOTE

CORRECTION

HYSEQ APPLYING SEQUENCING TECHNOLOGY TO DIAGNOSTICS IN DEAL WITH

SEQUENCING P53 GENE LINKS MUTATIONS TO THERAPIES, SURVIVAL IN 316

RHONE-POULENC'S TAXOTERE GETS NOD OF APPROVAL BY FDA PANEL

MATRIX PHARMACEUTICALS BUCKS RECENT TREND; $47M PUBLIC OFFERING BETTER